Kisspeptin in the Evaluation of Delayed Puberty
Sponsor: Massachusetts General Hospital
Listed as NCT01438034, this PHASE1 trial focuses on Delayed Puberty and GnRH Deficiency and remains completed. Sponsored by Massachusetts General Hospital, it has been updated 15 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Nov 2023 — Jul 2024 [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Aug 2023 — Nov 2023 [monthly]
Recruiting PHASE1
-
Sep 2022 — Aug 2023 [monthly]
Recruiting PHASE1
▶ Show 10 earlier versions
-
Sep 2021 — Sep 2022 [monthly]
Recruiting PHASE1
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE1
-
Jul 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Jan 2020 — Jul 2020 [monthly]
Recruiting PHASE1
-
Jul 2019 — Jan 2020 [monthly]
Recruiting PHASE1
-
Jan 2019 — Jul 2019 [monthly]
Recruiting PHASE1
-
Jul 2018 — Jan 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .